SAGE Therapeutics Announces Fourth Quarter And Full Year 2016 Financial Results And Provides Corporate Update Post author:Sam Post published:February 22, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like SEC Filings Reveal GlaxoSmithKline's 13% Stake in This Massachusetts Biotech November 16, 2017 AstraZeneca Canada Release: Pan-Canadian Oncology Drug Review Recommendation Supports The Use Of Tagrisso (Osimertinib) As The Standard Of Care For T790M Mutated Non-Small Cell Lung Cancer May 7, 2017 Eagle Pharma Announces New Patents Issued For Bendeka February 20, 2017
AstraZeneca Canada Release: Pan-Canadian Oncology Drug Review Recommendation Supports The Use Of Tagrisso (Osimertinib) As The Standard Of Care For T790M Mutated Non-Small Cell Lung Cancer May 7, 2017